申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US10301306B2
公开(公告)日:2019-05-28
Compounds having Formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, are useful as kinase modulators, including RIPK3 modulation. All the variables defined herein.
具有式(I)的化合物及其对映体、非对映体、立体异构体、药学上可接受的盐类可用作激酶调节剂,包括 RIPK3 调节剂。本文定义的所有变量。